Author

Geyun Chang

Observed name: Ge-Yun Chang

Institutions: Chinese Academy of Medical Sciences & Peking Union Medical College, Peking University People's Hospital

Observed institutions: Chinese Academy of Medical Sciences & Peking Union Medical College, Peking University People's Hospital, Cancer Hospital of Chinese Academy of Medical Sciences, First Affiliated Hospital of Zhengzhou University, Aviation General Hospital, State Key Laboratory of Molecular Oncology

ORCID: 0000-0002-9882-6278

Observed ORCID: 0000-0002-9882-6278

OpenAlex ID: A5070720476

MicroRNA-4461 derived from bone marrow mesenchymal stem cell exosomes inhibits tumorigenesis by downregulating COPB2 expression in colorectal cancer

2019 · Hui-Li Chen, Jiu-Jiang Li, et al. · Bioscience Biotechnology and Biochemistry · 57

Reliability analysis of exonic-breakpoint fusions identified by DNA sequencing for predicting the efficacy of targeted therapy in non-small cell lung cancer

2022 · Weihua Li, Rui Wan, et al. · BMC Medicine · 22

TP53 mutations in circulating tumor DNA in advanced epidermal growth factor receptor-mutant lung adenocarcinoma patients treated with gefitinib

2021 · Ruofei Yu, Hua Bai, et al. · Translational Oncology · 21

Correlations of switch/sucrose nonfermentable complex mutations with clinical outcomes in advanced non–small cell lung cancer

2022 · Geyun Chang, Weihua Li, et al. · Thoracic Cancer · 7

Establishment of prognostic nomograms for predicting the progression free survival of EGFR ‐sensitizing mutation, advanced lung cancer patients treated with EGFR‐TKIs

2022 · Xinyang Du, Hua Bai, et al. · Thoracic Cancer · 7

Induction therapy with dabrafenib, trametinib, and PD-1 inhibitor and surgical conversion in unresectable stage III non-small cell lung cancers with BRAF V600E mutation: 2 cases

2025 · Sida Cheng, Ruijie Zhang, et al. · Lung Cancer · 4

Discovery of a novel ROS-based signature for predicting prognosis and immunosuppressive tumor microenvironment in lung adenocarcinoma

2024 · Yufeng Guo, Geyun Chang, et al. · Journal of Cancer · 3

Deciphering the predictive value of senescence-related signature in lung adenocarcinoma: Implications for antitumor immunity and immunotherapy efficacy

2024 · Yufeng Guo, Yang Wang, et al. · Heliyon · 1

Adjuvant chemotherapy for completely resected stage IB–IIA non-small cell lung cancer according to the AJCC 8th edition staging system: a real-world retrospective cohort study based on the SEER database

2026 · Zewen Sun, Changtai Zhao, et al. · Translational Lung Cancer Research

Effect of neoadjuvant vs. adjuvant systemic therapy on survival in patients with surgical resected limited stage small-cell lung cancer: a real-world retrospective cohort study from SEER database

2025 · Zewen Sun, Yan Ju, et al. · Translational Lung Cancer Research

Neoadjuvant cadonilimab plus anlotinib followed by surgery for locally advanced esophageal squamous cell carcinoma: A single arm, phase 2 trial.

2025 · Wenhan Weng, Heng Zhao, et al. · Journal of Clinical Oncology

Neoadjuvant toripalimab plus chemotherapy for resectable stage II-IIIB non-squamous non-small cell lung cancer with EGFR mutations: A multi-center, multi-cohort, exploratory study.

2024 · Sida Cheng, Zihan Wei, et al. · Journal of Clinical Oncology

Erratum to ‘Evolution and genotypic characteristics of small cell lung cancer transformation in non-small cell lung carcinomas’ [Journal of the National Cancer Center, 1 (2021), 4: 153-162]

2022 · Jia Zhong, Xiaoting Li, et al. · Journal of the National Cancer Center

Clinical effects of vinorelbine combined with cisplatin in the treatment of patients with advanced breast cancer

2010 · Geyun Chang, Liuxing Wang · Central Plains Medical Journal

Works count: 14

Citation count: 122

H-index: 5

I10-index: 3